Cargando…
The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
There is a need for new, cost-effective drugs to treat leishmaniasis. A strategy based on traditional medicine practiced in Bolivia led to the discovery of the 2-substituted quinoline series as a source of molecules with antileishmanial activity and low toxicity. This review documents the developmen...
Autores principales: | Loiseau, Philippe M., Balaraman, Kaluvu, Barratt, Gillian, Pomel, Sébastien, Durand, Rémy, Frézard, Frédéric, Figadère, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000572/ https://www.ncbi.nlm.nih.gov/pubmed/35408712 http://dx.doi.org/10.3390/molecules27072313 |
Ejemplares similares
-
Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum
por: Obeid, Sameh, et al.
Publicado: (2023) -
Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against Leishmania donovani
por: Cabral, Lília I. L., et al.
Publicado: (2020) -
Alkyl-Resorcinol Derivatives as Inhibitors of GDP-Mannose Pyrophosphorylase with Antileishmanial Activities
por: Levaique, Hélène, et al.
Publicado: (2021) -
Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance
por: Loiseau, P.M., et al.
Publicado: (2011) -
Inhibition of
in vitro Ebola infection by anti-parasitic quinoline derivatives
por: Goyal, Shawn, et al.
Publicado: (2020)